The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice

Open Access

Peer-reviewed

Research Article

Lucía Cea Soriano,

Affiliation Spanish Centre for Pharmacoepidemiologic Research, Madrid, Spain
⨯
Montse Soriano-Gabarró,

Affiliation Epidemiology, Bayer Pharma AG, Berlin, Germany
⨯
Luis A. García Rodríguez

* E-mail: lagarcia@ceife.es

Affiliation Spanish Centre for Pharmacoepidemiologic Research, Madrid, Spain
⨯

Reader Comments (0)

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Cancer epidemiology
Is the Subject Area "Cancer epidemiology" applicable to this article?

Thanks for your feedback.
NSAIDs
Is the Subject Area "NSAIDs" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Primary care
Is the Subject Area "Primary care" applicable to this article?

Thanks for your feedback.
Age groups
Is the Subject Area "Age groups" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.